Cite
XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.
MLA
Dai, Weimin, et al. “XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.” Cell Transplantation, vol. 31, Jan. 2022, p. 9636897221092778. EBSCOhost, https://doi.org/10.1177/09636897221092778.
APA
Dai, W., Wu, A., Li, Y., Yu, G., & Yan, X. (2022). XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair. Cell Transplantation, 31, 9636897221092778. https://doi.org/10.1177/09636897221092778
Chicago
Dai, Weimin, An Wu, Yunping Li, Guofeng Yu, and Xinjiang Yan. 2022. “XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.” Cell Transplantation 31 (January): 9636897221092778. doi:10.1177/09636897221092778.